CN111956707A - Method for improving growth speed of saccharomyces cerevisiae and content of effective components in plants by using red light - Google Patents
Method for improving growth speed of saccharomyces cerevisiae and content of effective components in plants by using red light Download PDFInfo
- Publication number
- CN111956707A CN111956707A CN202010021634.0A CN202010021634A CN111956707A CN 111956707 A CN111956707 A CN 111956707A CN 202010021634 A CN202010021634 A CN 202010021634A CN 111956707 A CN111956707 A CN 111956707A
- Authority
- CN
- China
- Prior art keywords
- plant
- saccharomyces cerevisiae
- skin
- fermentation
- concentration
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 238000000034 method Methods 0.000 title claims abstract description 79
- 240000004808 Saccharomyces cerevisiae Species 0.000 title claims abstract description 49
- 235000014680 Saccharomyces cerevisiae Nutrition 0.000 title claims abstract description 49
- 238000000855 fermentation Methods 0.000 claims abstract description 94
- 230000004151 fermentation Effects 0.000 claims abstract description 94
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 claims abstract description 57
- 230000001965 increasing effect Effects 0.000 claims abstract description 41
- 239000000419 plant extract Substances 0.000 claims abstract description 28
- 241000894006 Bacteria Species 0.000 claims abstract description 24
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 17
- 239000000203 mixture Substances 0.000 claims abstract description 11
- 230000001678 irradiating effect Effects 0.000 claims abstract description 8
- 241000196324 Embryophyta Species 0.000 claims description 118
- 102000016942 Elastin Human genes 0.000 claims description 27
- 108010014258 Elastin Proteins 0.000 claims description 27
- 230000000694 effects Effects 0.000 claims description 27
- 229920002549 elastin Polymers 0.000 claims description 27
- 244000005700 microbiome Species 0.000 claims description 27
- 238000002360 preparation method Methods 0.000 claims description 19
- 230000001737 promoting effect Effects 0.000 claims description 19
- 244000183331 Nephelium lappaceum Species 0.000 claims description 15
- 235000007861 rambutan Nutrition 0.000 claims description 15
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 claims description 12
- 230000035755 proliferation Effects 0.000 claims description 12
- 239000003963 antioxidant agent Substances 0.000 claims description 11
- 230000004130 lipolysis Effects 0.000 claims description 11
- 230000028327 secretion Effects 0.000 claims description 10
- 240000006024 Lactobacillus plantarum Species 0.000 claims description 9
- 235000013965 Lactobacillus plantarum Nutrition 0.000 claims description 9
- 235000013305 food Nutrition 0.000 claims description 9
- 229940072205 lactobacillus plantarum Drugs 0.000 claims description 9
- 230000009467 reduction Effects 0.000 claims description 9
- 230000003078 antioxidant effect Effects 0.000 claims description 8
- 230000002708 enhancing effect Effects 0.000 claims description 8
- 239000008103 glucose Substances 0.000 claims description 8
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 claims description 8
- 238000000605 extraction Methods 0.000 claims description 6
- 235000013824 polyphenols Nutrition 0.000 claims description 6
- 239000004480 active ingredient Substances 0.000 claims description 5
- 239000003814 drug Substances 0.000 claims description 5
- 239000004310 lactic acid Substances 0.000 claims description 4
- 235000014655 lactic acid Nutrition 0.000 claims description 4
- 241000589220 Acetobacter Species 0.000 claims description 2
- 239000002417 nutraceutical Substances 0.000 claims description 2
- 235000021436 nutraceutical agent Nutrition 0.000 claims description 2
- 244000235858 Acetobacter xylinum Species 0.000 claims 3
- 235000002837 Acetobacter xylinum Nutrition 0.000 claims 3
- 125000004402 polyphenol group Chemical group 0.000 claims 1
- 230000001603 reducing effect Effects 0.000 abstract description 6
- 241000186660 Lactobacillus Species 0.000 abstract 2
- 229940039696 lactobacillus Drugs 0.000 abstract 2
- 239000000047 product Substances 0.000 description 63
- 210000003491 skin Anatomy 0.000 description 46
- 239000002609 medium Substances 0.000 description 29
- 239000003795 chemical substances by application Substances 0.000 description 26
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 22
- 210000004027 cell Anatomy 0.000 description 20
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 18
- 239000000243 solution Substances 0.000 description 18
- 102000016267 Leptin Human genes 0.000 description 12
- 108010092277 Leptin Proteins 0.000 description 12
- NRYBAZVQPHGZNS-ZSOCWYAHSA-N leptin Chemical compound O=C([C@H](CO)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC=1C2=CC=CC=C2NC=1)NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](NC(=O)[C@H](CC(O)=O)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H](CO)NC(=O)CNC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](N)CC(C)C)CCSC)N1CCC[C@H]1C(=O)NCC(=O)N[C@@H](CS)C(O)=O NRYBAZVQPHGZNS-ZSOCWYAHSA-N 0.000 description 12
- 229940039781 leptin Drugs 0.000 description 12
- 235000006708 antioxidants Nutrition 0.000 description 10
- 230000036252 glycation Effects 0.000 description 10
- UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 10
- 229960005070 ascorbic acid Drugs 0.000 description 9
- 239000003153 chemical reaction reagent Substances 0.000 description 9
- 238000002347 injection Methods 0.000 description 9
- 239000007924 injection Substances 0.000 description 9
- 230000002829 reductive effect Effects 0.000 description 9
- 235000000069 L-ascorbic acid Nutrition 0.000 description 8
- 239000002211 L-ascorbic acid Substances 0.000 description 8
- LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 8
- 239000007788 liquid Substances 0.000 description 8
- 239000002953 phosphate buffered saline Substances 0.000 description 8
- 244000283763 Acetobacter aceti Species 0.000 description 7
- 235000007847 Acetobacter aceti Nutrition 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 238000006243 chemical reaction Methods 0.000 description 7
- 230000004069 differentiation Effects 0.000 description 7
- 239000000843 powder Substances 0.000 description 7
- 229960005322 streptomycin Drugs 0.000 description 7
- 230000037303 wrinkles Effects 0.000 description 7
- 108010005094 Advanced Glycation End Products Proteins 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 241001629494 Nephelium Species 0.000 description 6
- NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 6
- 239000000463 material Substances 0.000 description 6
- 239000012086 standard solution Substances 0.000 description 6
- 239000000126 substance Substances 0.000 description 6
- 238000012360 testing method Methods 0.000 description 6
- 102000008186 Collagen Human genes 0.000 description 5
- 108010035532 Collagen Proteins 0.000 description 5
- 241000699666 Mus <mouse, genus> Species 0.000 description 5
- 229930182555 Penicillin Natural products 0.000 description 5
- JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 5
- 239000001888 Peptone Substances 0.000 description 5
- 108010080698 Peptones Proteins 0.000 description 5
- 239000006096 absorbing agent Substances 0.000 description 5
- 210000001789 adipocyte Anatomy 0.000 description 5
- 238000004458 analytical method Methods 0.000 description 5
- 239000007864 aqueous solution Substances 0.000 description 5
- 210000004271 bone marrow stromal cell Anatomy 0.000 description 5
- 239000002738 chelating agent Substances 0.000 description 5
- 229920001436 collagen Polymers 0.000 description 5
- -1 elixir (elixir) Substances 0.000 description 5
- 238000011156 evaluation Methods 0.000 description 5
- 238000002474 experimental method Methods 0.000 description 5
- 239000003349 gelling agent Substances 0.000 description 5
- 239000001963 growth medium Substances 0.000 description 5
- 230000003647 oxidation Effects 0.000 description 5
- 238000007254 oxidation reaction Methods 0.000 description 5
- 229940049954 penicillin Drugs 0.000 description 5
- 235000019319 peptone Nutrition 0.000 description 5
- 150000008442 polyphenolic compounds Chemical group 0.000 description 5
- 210000000229 preadipocyte Anatomy 0.000 description 5
- 230000008569 process Effects 0.000 description 5
- 239000002904 solvent Substances 0.000 description 5
- 108090000790 Enzymes Proteins 0.000 description 4
- 102000004190 Enzymes Human genes 0.000 description 4
- 208000008589 Obesity Diseases 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- 102000004142 Trypsin Human genes 0.000 description 4
- 108090000631 Trypsin Proteins 0.000 description 4
- 238000002835 absorbance Methods 0.000 description 4
- 239000007795 chemical reaction product Substances 0.000 description 4
- 239000008121 dextrose Substances 0.000 description 4
- 238000010790 dilution Methods 0.000 description 4
- 239000012895 dilution Substances 0.000 description 4
- 239000003937 drug carrier Substances 0.000 description 4
- 235000013399 edible fruits Nutrition 0.000 description 4
- 239000003995 emulsifying agent Substances 0.000 description 4
- 239000000839 emulsion Substances 0.000 description 4
- 239000003623 enhancer Substances 0.000 description 4
- 229940088598 enzyme Drugs 0.000 description 4
- 235000021107 fermented food Nutrition 0.000 description 4
- 239000012091 fetal bovine serum Substances 0.000 description 4
- LNTHITQWFMADLM-UHFFFAOYSA-N gallic acid Chemical compound OC(=O)C1=CC(O)=C(O)C(O)=C1 LNTHITQWFMADLM-UHFFFAOYSA-N 0.000 description 4
- 150000002632 lipids Chemical class 0.000 description 4
- 238000004519 manufacturing process Methods 0.000 description 4
- 235000020824 obesity Nutrition 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000003381 stabilizer Substances 0.000 description 4
- 239000000725 suspension Substances 0.000 description 4
- 239000012588 trypsin Substances 0.000 description 4
- 239000001993 wax Substances 0.000 description 4
- 102000004877 Insulin Human genes 0.000 description 3
- 108090001061 Insulin Proteins 0.000 description 3
- 239000013543 active substance Substances 0.000 description 3
- 239000000654 additive Substances 0.000 description 3
- 239000002671 adjuvant Substances 0.000 description 3
- 230000032683 aging Effects 0.000 description 3
- 238000003556 assay Methods 0.000 description 3
- 230000015572 biosynthetic process Effects 0.000 description 3
- 239000006185 dispersion Substances 0.000 description 3
- 230000002500 effect on skin Effects 0.000 description 3
- 239000006260 foam Substances 0.000 description 3
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 3
- 239000000499 gel Substances 0.000 description 3
- 229940088597 hormone Drugs 0.000 description 3
- 239000005556 hormone Substances 0.000 description 3
- 239000002054 inoculum Substances 0.000 description 3
- 229940125396 insulin Drugs 0.000 description 3
- 239000002085 irritant Substances 0.000 description 3
- 239000006210 lotion Substances 0.000 description 3
- 238000012423 maintenance Methods 0.000 description 3
- 239000007758 minimum essential medium Substances 0.000 description 3
- 239000011259 mixed solution Substances 0.000 description 3
- 210000003205 muscle Anatomy 0.000 description 3
- 239000002674 ointment Substances 0.000 description 3
- 102000004169 proteins and genes Human genes 0.000 description 3
- 108090000623 proteins and genes Proteins 0.000 description 3
- 210000002966 serum Anatomy 0.000 description 3
- 239000007921 spray Substances 0.000 description 3
- 238000010186 staining Methods 0.000 description 3
- 239000004094 surface-active agent Substances 0.000 description 3
- 239000006188 syrup Substances 0.000 description 3
- 235000020357 syrup Nutrition 0.000 description 3
- 244000063299 Bacillus subtilis Species 0.000 description 2
- 235000014469 Bacillus subtilis Nutrition 0.000 description 2
- 241000195940 Bryophyta Species 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- 206010013786 Dry skin Diseases 0.000 description 2
- 238000002965 ELISA Methods 0.000 description 2
- 238000008157 ELISA kit Methods 0.000 description 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 2
- 229910021578 Iron(III) chloride Inorganic materials 0.000 description 2
- 229930195725 Mannitol Natural products 0.000 description 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 2
- 101100181592 Mus musculus Lep gene Proteins 0.000 description 2
- ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
- 241001093760 Sapindaceae Species 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 238000000692 Student's t-test Methods 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 239000003070 absorption delaying agent Substances 0.000 description 2
- 238000010521 absorption reaction Methods 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000000443 aerosol Substances 0.000 description 2
- SHGAZHPCJJPHSC-YCNIQYBTSA-N all-trans-retinoic acid Chemical compound OC(=O)\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C SHGAZHPCJJPHSC-YCNIQYBTSA-N 0.000 description 2
- 235000014104 aloe vera supplement Nutrition 0.000 description 2
- 229940035676 analgesics Drugs 0.000 description 2
- 239000000730 antalgic agent Substances 0.000 description 2
- 239000000058 anti acne agent Substances 0.000 description 2
- 230000003712 anti-aging effect Effects 0.000 description 2
- 229940121363 anti-inflammatory agent Drugs 0.000 description 2
- 239000002260 anti-inflammatory agent Substances 0.000 description 2
- 230000001139 anti-pruritic effect Effects 0.000 description 2
- 229940124340 antiacne agent Drugs 0.000 description 2
- 239000003213 antiperspirant Substances 0.000 description 2
- 239000003908 antipruritic agent Substances 0.000 description 2
- 238000003149 assay kit Methods 0.000 description 2
- 235000015173 baked goods and baking mixes Nutrition 0.000 description 2
- 239000011230 binding agent Substances 0.000 description 2
- 239000007844 bleaching agent Substances 0.000 description 2
- 239000000872 buffer Substances 0.000 description 2
- 239000002775 capsule Substances 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 2
- 235000005487 catechin Nutrition 0.000 description 2
- 238000004113 cell culture Methods 0.000 description 2
- 239000003086 colorant Substances 0.000 description 2
- 150000001875 compounds Chemical class 0.000 description 2
- 239000002537 cosmetic Substances 0.000 description 2
- 239000006071 cream Substances 0.000 description 2
- 239000012228 culture supernatant Substances 0.000 description 2
- 210000004207 dermis Anatomy 0.000 description 2
- 238000001514 detection method Methods 0.000 description 2
- 238000011161 development Methods 0.000 description 2
- 230000018109 developmental process Effects 0.000 description 2
- UREBDLICKHMUKA-CXSFZGCWSA-N dexamethasone Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1C[C@@H](C)[C@@](C(=O)CO)(O)[C@@]1(C)C[C@@H]2O UREBDLICKHMUKA-CXSFZGCWSA-N 0.000 description 2
- 229960003957 dexamethasone Drugs 0.000 description 2
- 238000010586 diagram Methods 0.000 description 2
- 235000015872 dietary supplement Nutrition 0.000 description 2
- 239000003085 diluting agent Substances 0.000 description 2
- 239000002270 dispersing agent Substances 0.000 description 2
- 238000010494 dissociation reaction Methods 0.000 description 2
- 230000005593 dissociations Effects 0.000 description 2
- 239000000284 extract Substances 0.000 description 2
- 210000002950 fibroblast Anatomy 0.000 description 2
- 235000013373 food additive Nutrition 0.000 description 2
- 239000002778 food additive Substances 0.000 description 2
- 239000003205 fragrance Substances 0.000 description 2
- 229940074391 gallic acid Drugs 0.000 description 2
- 235000004515 gallic acid Nutrition 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 239000008187 granular material Substances 0.000 description 2
- 235000013402 health food Nutrition 0.000 description 2
- 229910052595 hematite Inorganic materials 0.000 description 2
- 239000011019 hematite Substances 0.000 description 2
- 239000003906 humectant Substances 0.000 description 2
- BJRNKVDFDLYUGJ-RMPHRYRLSA-N hydroquinone O-beta-D-glucopyranoside Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@H]1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-RMPHRYRLSA-N 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 239000007928 intraperitoneal injection Substances 0.000 description 2
- 238000010253 intravenous injection Methods 0.000 description 2
- 229910052742 iron Inorganic materials 0.000 description 2
- RBTARNINKXHZNM-UHFFFAOYSA-K iron trichloride Chemical compound Cl[Fe](Cl)Cl RBTARNINKXHZNM-UHFFFAOYSA-K 0.000 description 2
- LIKBJVNGSGBSGK-UHFFFAOYSA-N iron(3+);oxygen(2-) Chemical compound [O-2].[O-2].[O-2].[Fe+3].[Fe+3] LIKBJVNGSGBSGK-UHFFFAOYSA-N 0.000 description 2
- 230000031700 light absorption Effects 0.000 description 2
- 230000000670 limiting effect Effects 0.000 description 2
- 239000000865 liniment Substances 0.000 description 2
- 239000002502 liposome Substances 0.000 description 2
- 239000000594 mannitol Substances 0.000 description 2
- 235000010355 mannitol Nutrition 0.000 description 2
- 229940016286 microcrystalline cellulose Drugs 0.000 description 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 2
- 239000008108 microcrystalline cellulose Substances 0.000 description 2
- 235000011929 mousse Nutrition 0.000 description 2
- 235000015097 nutrients Nutrition 0.000 description 2
- 239000003002 pH adjusting agent Substances 0.000 description 2
- 230000035515 penetration Effects 0.000 description 2
- 235000019271 petrolatum Nutrition 0.000 description 2
- 239000000546 pharmaceutical excipient Substances 0.000 description 2
- 239000008055 phosphate buffer solution Substances 0.000 description 2
- ZJAOAACCNHFJAH-UHFFFAOYSA-N phosphonoformic acid Chemical compound OC(=O)P(O)(O)=O ZJAOAACCNHFJAH-UHFFFAOYSA-N 0.000 description 2
- 229940023488 pill Drugs 0.000 description 2
- 239000006187 pill Substances 0.000 description 2
- 238000001556 precipitation Methods 0.000 description 2
- 238000004321 preservation Methods 0.000 description 2
- 239000003380 propellant Substances 0.000 description 2
- 239000002994 raw material Substances 0.000 description 2
- 238000011160 research Methods 0.000 description 2
- 239000000344 soap Substances 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
- 210000000434 stratum corneum Anatomy 0.000 description 2
- 238000010254 subcutaneous injection Methods 0.000 description 2
- 239000007929 subcutaneous injection Substances 0.000 description 2
- 239000006228 supernatant Substances 0.000 description 2
- 239000000375 suspending agent Substances 0.000 description 2
- 239000003826 tablet Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- 230000000699 topical effect Effects 0.000 description 2
- 238000011282 treatment Methods 0.000 description 2
- 229960001727 tretinoin Drugs 0.000 description 2
- YNJBWRMUSHSURL-UHFFFAOYSA-N trichloroacetic acid Chemical compound OC(=O)C(Cl)(Cl)Cl YNJBWRMUSHSURL-UHFFFAOYSA-N 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 239000000080 wetting agent Substances 0.000 description 2
- 239000003357 wound healing promoting agent Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 description 1
- IUKHSWVQCORLGA-AYXADEGOSA-N (3s,4r,5r)-1,3,4,5,6-pentahydroxyhexan-2-one Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO.OC[C@@H](O)[C@@H](O)[C@H](O)C(=O)CO IUKHSWVQCORLGA-AYXADEGOSA-N 0.000 description 1
- PRDFBSVERLRRMY-UHFFFAOYSA-N 2'-(4-ethoxyphenyl)-5-(4-methylpiperazin-1-yl)-2,5'-bibenzimidazole Chemical compound C1=CC(OCC)=CC=C1C1=NC2=CC=C(C=3NC4=CC(=CC=C4N=3)N3CCN(C)CC3)C=C2N1 PRDFBSVERLRRMY-UHFFFAOYSA-N 0.000 description 1
- APIXJSLKIYYUKG-UHFFFAOYSA-N 3 Isobutyl 1 methylxanthine Chemical compound O=C1N(C)C(=O)N(CC(C)C)C2=C1N=CN2 APIXJSLKIYYUKG-UHFFFAOYSA-N 0.000 description 1
- 241000186361 Actinobacteria <class> Species 0.000 description 1
- 235000001674 Agaricus brunnescens Nutrition 0.000 description 1
- 241000219498 Alnus glutinosa Species 0.000 description 1
- 201000001320 Atherosclerosis Diseases 0.000 description 1
- 206010003694 Atrophy Diseases 0.000 description 1
- 241000193388 Bacillus thuringiensis Species 0.000 description 1
- 108091003079 Bovine Serum Albumin Proteins 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-L Carbonate Chemical compound [O-]C([O-])=O BVKZGUZCCUSVTD-UHFFFAOYSA-L 0.000 description 1
- 208000002177 Cataract Diseases 0.000 description 1
- 229920000832 Cutin Polymers 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- 201000004624 Dermatitis Diseases 0.000 description 1
- 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
- 239000004150 EU approved colour Substances 0.000 description 1
- CWYNVVGOOAEACU-UHFFFAOYSA-N Fe2+ Chemical compound [Fe+2] CWYNVVGOOAEACU-UHFFFAOYSA-N 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 241000282412 Homo Species 0.000 description 1
- OWIKHYCFFJSOEH-UHFFFAOYSA-N Isocyanic acid Chemical compound N=C=O OWIKHYCFFJSOEH-UHFFFAOYSA-N 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 239000004909 Moisturizer Substances 0.000 description 1
- 241000228347 Monascus <ascomycete fungus> Species 0.000 description 1
- 241000699660 Mus musculus Species 0.000 description 1
- 244000183278 Nephelium litchi Species 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 229930040373 Paraformaldehyde Natural products 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 230000010757 Reduction Activity Effects 0.000 description 1
- 208000001647 Renal Insufficiency Diseases 0.000 description 1
- 244000000231 Sesamum indicum Species 0.000 description 1
- 235000003434 Sesamum indicum Nutrition 0.000 description 1
- 206010040954 Skin wrinkling Diseases 0.000 description 1
- 241000223259 Trichoderma Species 0.000 description 1
- 239000013504 Triton X-100 Substances 0.000 description 1
- 229920004890 Triton X-100 Polymers 0.000 description 1
- 230000001133 acceleration Effects 0.000 description 1
- 210000000577 adipose tissue Anatomy 0.000 description 1
- 239000004964 aerogel Substances 0.000 description 1
- 150000001298 alcohols Chemical class 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 125000003277 amino group Chemical group 0.000 description 1
- HAMNKKUPIHEESI-UHFFFAOYSA-N aminoguanidine Chemical compound NNC(N)=N HAMNKKUPIHEESI-UHFFFAOYSA-N 0.000 description 1
- 230000003625 amylolytic effect Effects 0.000 description 1
- 229940035674 anesthetics Drugs 0.000 description 1
- 230000003042 antagnostic effect Effects 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 230000001166 anti-perspirative effect Effects 0.000 description 1
- 230000001153 anti-wrinkle effect Effects 0.000 description 1
- 229940088710 antibiotic agent Drugs 0.000 description 1
- 239000003524 antilipemic agent Substances 0.000 description 1
- 210000003056 antler Anatomy 0.000 description 1
- 230000036528 appetite Effects 0.000 description 1
- 235000019789 appetite Nutrition 0.000 description 1
- 229960000271 arbutin Drugs 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 230000037444 atrophy Effects 0.000 description 1
- 229940097012 bacillus thuringiensis Drugs 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000003855 balanced salt solution Substances 0.000 description 1
- 230000004888 barrier function Effects 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000008901 benefit Effects 0.000 description 1
- 235000013361 beverage Nutrition 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 239000012888 bovine serum Substances 0.000 description 1
- 229940046011 buccal tablet Drugs 0.000 description 1
- 239000006189 buccal tablet Substances 0.000 description 1
- 238000011088 calibration curve Methods 0.000 description 1
- 229940041514 candida albicans extract Drugs 0.000 description 1
- 150000001765 catechin Chemical class 0.000 description 1
- 238000000423 cell based assay Methods 0.000 description 1
- 239000006285 cell suspension Substances 0.000 description 1
- 238000005119 centrifugation Methods 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 238000004737 colorimetric analysis Methods 0.000 description 1
- 238000007796 conventional method Methods 0.000 description 1
- 238000001816 cooling Methods 0.000 description 1
- 239000003246 corticosteroid Substances 0.000 description 1
- 229960001334 corticosteroids Drugs 0.000 description 1
- 238000012258 culturing Methods 0.000 description 1
- 230000001461 cytolytic effect Effects 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 239000003599 detergent Substances 0.000 description 1
- 206010012601 diabetes mellitus Diseases 0.000 description 1
- 238000007865 diluting Methods 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 239000007884 disintegrant Substances 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- 239000002552 dosage form Substances 0.000 description 1
- 239000012154 double-distilled water Substances 0.000 description 1
- 239000006196 drop Substances 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 210000004177 elastic tissue Anatomy 0.000 description 1
- 230000008030 elimination Effects 0.000 description 1
- 238000003379 elimination reaction Methods 0.000 description 1
- 239000003974 emollient agent Substances 0.000 description 1
- 230000001804 emulsifying effect Effects 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 230000007613 environmental effect Effects 0.000 description 1
- 230000002255 enzymatic effect Effects 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 230000005284 excitation Effects 0.000 description 1
- 230000001815 facial effect Effects 0.000 description 1
- 229910001448 ferrous ion Inorganic materials 0.000 description 1
- 239000000945 filler Substances 0.000 description 1
- 239000012530 fluid Substances 0.000 description 1
- 230000037406 food intake Effects 0.000 description 1
- 235000011194 food seasoning agent Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 229960005102 foscarnet Drugs 0.000 description 1
- 239000003193 general anesthetic agent Substances 0.000 description 1
- 150000002334 glycols Chemical class 0.000 description 1
- 230000005484 gravity Effects 0.000 description 1
- 230000036541 health Effects 0.000 description 1
- 231100000206 health hazard Toxicity 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- 229920002674 hyaluronan Polymers 0.000 description 1
- 229960003160 hyaluronic acid Drugs 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000003345 hyperglycaemic effect Effects 0.000 description 1
- 206010020718 hyperplasia Diseases 0.000 description 1
- 238000003125 immunofluorescent labeling Methods 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 230000006698 induction Effects 0.000 description 1
- 239000003262 industrial enzyme Substances 0.000 description 1
- 230000000977 initiatory effect Effects 0.000 description 1
- 238000011081 inoculation Methods 0.000 description 1
- 230000008810 intracellular oxidative stress Effects 0.000 description 1
- 238000010255 intramuscular injection Methods 0.000 description 1
- 239000007927 intramuscular injection Substances 0.000 description 1
- 231100000021 irritant Toxicity 0.000 description 1
- 238000002955 isolation Methods 0.000 description 1
- DLRVVLDZNNYCBX-RTPHMHGBSA-N isomaltose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)C(O)O1 DLRVVLDZNNYCBX-RTPHMHGBSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 150000002576 ketones Chemical group 0.000 description 1
- 201000006370 kidney failure Diseases 0.000 description 1
- BEJNERDRQOWKJM-UHFFFAOYSA-N kojic acid Chemical compound OCC1=CC(=O)C(O)=CO1 BEJNERDRQOWKJM-UHFFFAOYSA-N 0.000 description 1
- 229960004705 kojic acid Drugs 0.000 description 1
- WZNJWVWKTVETCG-UHFFFAOYSA-N kojic acid Natural products OC(=O)C(N)CN1C=CC(=O)C(O)=C1 WZNJWVWKTVETCG-UHFFFAOYSA-N 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 239000000314 lubricant Substances 0.000 description 1
- 230000001050 lubricating effect Effects 0.000 description 1
- 239000002932 luster Substances 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 230000037323 metabolic rate Effects 0.000 description 1
- 230000000813 microbial effect Effects 0.000 description 1
- 238000002156 mixing Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000001333 moisturizer Effects 0.000 description 1
- LPUQAYUQRXPFSQ-DFWYDOINSA-M monosodium L-glutamate Chemical compound [Na+].[O-]C(=O)[C@@H](N)CCC(O)=O LPUQAYUQRXPFSQ-DFWYDOINSA-M 0.000 description 1
- 235000013923 monosodium glutamate Nutrition 0.000 description 1
- 239000004223 monosodium glutamate Substances 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 150000007523 nucleic acids Chemical class 0.000 description 1
- 108020004707 nucleic acids Proteins 0.000 description 1
- 102000039446 nucleic acids Human genes 0.000 description 1
- 229940006093 opthalmologic coloring agent diagnostic Drugs 0.000 description 1
- NIFHFRBCEUSGEE-UHFFFAOYSA-N oxalic acid Chemical compound OC(=O)C(O)=O.OC(=O)C(O)=O NIFHFRBCEUSGEE-UHFFFAOYSA-N 0.000 description 1
- BJRNKVDFDLYUGJ-UHFFFAOYSA-N p-hydroxyphenyl beta-D-alloside Natural products OC1C(O)C(O)C(CO)OC1OC1=CC=C(O)C=C1 BJRNKVDFDLYUGJ-UHFFFAOYSA-N 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 239000012188 paraffin wax Substances 0.000 description 1
- 229920002866 paraformaldehyde Polymers 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- 239000008188 pellet Substances 0.000 description 1
- 239000000575 pesticide Substances 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000002035 prolonged effect Effects 0.000 description 1
- 229940024999 proteolytic enzymes for treatment of wounds and ulcers Drugs 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 230000001105 regulatory effect Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229930002330 retinoic acid Natural products 0.000 description 1
- 238000007788 roughening Methods 0.000 description 1
- 238000010079 rubber tapping Methods 0.000 description 1
- 238000012216 screening Methods 0.000 description 1
- 230000009759 skin aging Effects 0.000 description 1
- 239000002002 slurry Substances 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000012064 sodium phosphate buffer Substances 0.000 description 1
- 229940054269 sodium pyruvate Drugs 0.000 description 1
- 235000019614 sour taste Nutrition 0.000 description 1
- 238000007619 statistical method Methods 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 239000000758 substrate Substances 0.000 description 1
- 235000019605 sweet taste sensations Nutrition 0.000 description 1
- 235000019640 taste Nutrition 0.000 description 1
- 239000003860 topical agent Substances 0.000 description 1
- 230000007306 turnover Effects 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 238000005406 washing Methods 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
- 238000003809 water extraction Methods 0.000 description 1
- 238000005303 weighing Methods 0.000 description 1
- 239000003871 white petrolatum Substances 0.000 description 1
- 239000012138 yeast extract Substances 0.000 description 1
Images
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/185—Magnoliopsida (dicotyledons)
- A61K36/77—Sapindaceae (Soapberry family), e.g. lychee or soapberry
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/105—Plant extracts, their artificial duplicates or their derivatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/96—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution
- A61K8/97—Cosmetics or similar toiletry preparations characterised by the composition containing materials, or derivatives thereof of undetermined constitution from algae, fungi, lichens or plants; from derivatives thereof
- A61K8/9783—Angiosperms [Magnoliophyta]
- A61K8/9789—Magnoliopsida [dicotyledons]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2236/00—Isolation or extraction methods of medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicine
- A61K2236/10—Preparation or pretreatment of starting material
- A61K2236/19—Preparation or pretreatment of starting material involving fermentation using yeast, bacteria or both; enzymatic treatment
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K2800/00—Properties of cosmetic compositions or active ingredients thereof or formulation aids used therein and process related aspects
- A61K2800/80—Process related aspects concerning the preparation of the cosmetic composition or the storage or application thereof
- A61K2800/85—Products or compounds obtained by fermentation, e.g. yoghurt, beer, wine
Abstract
The invention relates to the field of plant extracts, in particular to a method for improving the growth speed of saccharomyces cerevisiae and the content of effective components in plants by using red light. The present invention provides a method for fermenting a plant, comprising the steps of: extracting a plant with water to obtain a plant extract; and sequentially fermenting the plant extract with saccharomyces cerevisiae, germ lactobacillus and acetic acid bacteria to obtain a plant fermented product, wherein the fermentation process comprises irradiating the plant extract, the saccharomyces cerevisiae, the germ lactobacillus and the acetic acid bacteria with a red light source with the wavelength of 620-750 nm. The method can be used for increasing the growth speed of the saccharomyces cerevisiae and the content of effective components in the plants. The invention also discloses a plant fermentation product prepared by the method, and the fermentation product can be used for preparing a composition for reducing skin fat.
Description
Technical Field
The invention relates to the field of plant extracts, in particular to a method for improving the growth speed of saccharomyces cerevisiae and the content of effective components in plants by using red light.
Background
Fat is an essential component in the human body, but excessive fat components cause damage to the human body. In countries with increasing national economy, the obesity problem is only increased but not reduced, so that in view of Asian regions, China can be a country with the increased amplitude of the next wave of obesity problem. Obesity should become a problem that needs to be solved at present.
In addition, glycation (glycation) is associated with skin and in vivo aging, and is more associated with diabetes which is a health hazard to people. The nature of the saccharification reaction is known as the Maillard reaction or carbonyl-amine browning, which is a non-enzymatic saccharification of the aldehyde (ketone) group of a sugar with an amino group-containing substance (e.g., a protein, peptide, amino acid, phospholipid, nucleic acid, or derivative thereof). Prolonged exposure to hyperglycemic conditions can lead to glucose autooxidation and protein glycation, leading to the formation of advanced glycation end products (AGEs). AGEs can cause various aging diseases such as skin wrinkles, cataract, atherosclerosis, kidney failure, etc.
The skin tissue is composed of epidermis, dermis and hypodermis, wherein the dermis contains a large amount of collagen and hyaluronic acid, and is closely related to the water retention and elasticity of the skin. The human skin can have the phenomena of oxidation, aging, rough skin or wrinkle generation and the like along with age, physiological factors or environmental factors, for example, the skin of normal young people has certain elasticity and tension, and when the expression muscle is relaxed, the skin can be quickly recovered to eliminate the wrinkle; but in the middle age, the skin begins to age obviously, becomes thin, hard, dry and has reduced tension; dermal collagen is reduced, elastic fibers are denatured and broken, so that the tension and elasticity of the skin are reduced, and therefore, the skin cannot recover quickly after the expression muscles are relaxed, and wrinkles are formed after the skin relaxes for a long time; and with the increase of age, the skin and subcutaneous tissues are more relaxed, and in addition, the atrophy or the loss of the facial supporting tissues and the softness of muscles, the skin slides and falls under the action of gravity to form deeper wrinkles. The rough skin is a skin trouble caused by an external important factor such as dryness, ultraviolet rays, an irritant substance such as a detergent or a chemical substance, or an internal important factor such as disturbance of hormone balance, and is accompanied by phenomena such as reduction of barrier function of stratum corneum, reduction of moisture content of stratum corneum, acceleration of epidermal turnover, and roughening of cutin caused by generation of scales. Therefore, if the cells on the skin lose their elasticity and moisture-retaining function, they may cause wrinkles, dryness and loss of luster.
The production of fermented food always relies on microorganisms which are inoculated into raw materials to produce required enzymes in the growth process, and the process of decomposing organic matters into beneficial substances in human life is called fermentation; so that the enzyme produced by the microorganism actually catalyzes the metabolic activity. The range of products obtained by fermentation is very wide, and the products range from pharmaceutical-grade products with very high unit price, such as hypolipidemic drugs or antibiotics, to industrial enzymes, such as amylolytic, cellulolytic, proteolytic enzymes and the like; also useful microorganisms for food, such as lactic acid bacteria, monascus, bacillus natto, edible and medicinal mushroom, etc., seasoning of monosodium glutamate, biological pesticide for agriculture, such as bacillus thuringiensis, or microorganisms of antagonistic bacteria such as bacillus subtilis, actinomycetes, trichoderma, etc.; further, the enzyme may be any of microorganisms added to animal feeds or directly added to feeds, microorganisms used for waste recovery, various pollution treatments and cleaning, and other special enzymes. In particular, in recent years, researchers have begun to perform fermentation treatment on plants (such as vegetables and fruits), and the obtained plant fermentation products can be used for improving human health. Accordingly, there has been an increasing demand for fermented foods.
However, conventional fermentation processes for producing fermentation products often require a significant amount of time for the microorganisms to grow and require industrial-scale fermentation equipment, such as fermentation tanks, which is very costly. Therefore, if a novel method for fermenting plants can be developed and can be used to increase the growth rate of saccharomyces cerevisiae and the content of effective components in plants, it would bring a great breakthrough to the art and benefit the wide population in need.
Disclosure of Invention
In view of the above, it is an object of the present invention to provide a method for fermenting plants, comprising the steps of: (a) extracting a plant with water to obtain a plant extract; and (b) sequentially performing a fermentation process on the plant extract, a Saccharomyces cerevisiae (Saccharomyces cerevisiae), a Lactobacillus plantarum (Lactobacillus plantarum) and an acetic acid bacterium (Acetobacter aceti) to obtain a plant fermentation product, wherein the fermentation process comprises irradiating the plant extract, the Saccharomyces cerevisiae, the Lactobacillus plantarum and the acetic acid bacterium with a red light source with a wavelength of 620-750 nm.
In one embodiment of the invention, the plant is rambutan (Nephelium lappacium).
In one embodiment of the present invention, prior to the extraction, a glucose having a concentration of 10% (w/w) based on the total weight is added.
In one embodiment of the present invention, the fermentation time of the saccharomyces cerevisiae is 1 to 2.5 days, the fermentation time of the lactobacillus plantarum is 1 to 3 days, and the fermentation time of the acetic acid bacterium is 3 to 10 days.
In an embodiment of the present invention, the concentration of the brewer's yeast is between 0.01-0.5% (v/v), the concentration of the germ lactic acid bacteria is between 0.01-0.25% (v/v), and the concentration of the acetic acid bacteria is between 3-10% (v/v).
In an embodiment of the present invention, the weight ratio of the plant to water is 1: 5-10.
In one embodiment of the present invention, in step (a), the temperature of the extraction is between 50 and 100 ℃, and the time of the extraction is between 0.5 and 1.5 hours.
Another object of the present invention is to provide a method for increasing the growth rate of Saccharomyces cerevisiae and the content of effective components in plants.
In one embodiment of the invention, the plant is rambutan (Nephelium lappacium) and the active ingredient is a polyphenol (polyphenol).
Another object of the present invention is to provide a plant fermentation product, which is prepared by the method of the above technical scheme.
Another object of the present invention is to provide a use of the plant fermentation product as described above for preparing a skin-care and fat-reducing composition.
In one embodiment of the present invention, the skin care includes enhancing the antioxidant capacity of the skin, enhancing the anti-glycation activity of the skin, and promoting elastin proliferation.
In one embodiment of the invention, the fat reduction includes promoting lipolysis and increasing leptin secretion.
In one embodiment of the present invention, the composition is in the form of a pharmaceutical, a nutraceutical, or a food product.
It is another object of the present invention to provide a method for increasing the growth rate of microorganisms, comprising the steps of: (a) extracting a plant with water to obtain a plant extract; and (b) performing a fermentation process on the plant extract and a microorganism to obtain a plant fermentation product, wherein the microorganism is Saccharomyces cerevisiae (Saccharomyces cerevisiae) or Acetobacter aceti (Acetobacter aceti), and the fermentation process comprises irradiating the plant extract and the microorganism with a red light source with a wavelength of 620-750 nm.
In one embodiment of the invention, the plant is rambutan (Nephelium lappacium).
In one embodiment of the present invention, prior to the extraction, a glucose having a concentration of 10% (w/w) based on the total weight is added.
In one embodiment of the present invention, the fermentation time of the microorganism is 1 to 3 days.
In one embodiment of the present invention, the concentration of the brewer's yeast is between 0.01-0.5% (v/v), and the concentration of the acetic acid bacteria is between 5% (v/v).
In one embodiment of the present invention, the growth rate of the brewers' yeast is increased by at least 47% and the growth rate of the acetic acid bacteria is increased by at least 22%.
In summary, the method for fermenting plants and the plant fermentation product prepared by the method of the present invention have the following effects: can increase the growth rate of microorganisms (such as Saccharomyces cerevisiae and Acetobacter) and the content of effective components in plants, and can improve the antioxidant capacity of skin, improve the anti-saccharification activity of skin, and promote the proliferation of elastin to achieve the effects of caring skin and beautifying skin. On the other hand, the plant fermentation product can achieve the effect of reducing fat by promoting lipolysis and increasing leptin secretion.
The following examples are presented to illustrate the present invention and are not to be construed as limiting the scope of the invention, which is intended to be limited only by the appended claims.
Drawings
FIG. 1 is a graph of data from a microorganism growth rate test;
figure 2 is a data plot of the analysis of the content of active ingredients in plants, wherein p represents <0.001 compared to the control group;
FIG. 3 is a data plot of the effectiveness of the plant fermentation product prepared by the method of the present invention in enhancing the antioxidant capacity of skin, wherein p is <0.05 as compared to a control;
FIG. 4 is a data plot of the efficacy of the plant fermentations prepared according to the present invention in enhancing anti-glycation activity of the skin, wherein p is <0.05 compared to a control;
FIG. 5 is a graph of data showing the efficacy of the plant fermentation product of the present invention in promoting elastin proliferation;
FIGS. 6A and 6B are cell staining graphs showing the effect of the plant fermentation product prepared by the method of the present invention on promoting elastin proliferation, wherein the dots represent the nucleus and the rest represent elastin;
FIG. 7 is a graph of data showing the efficacy of the plant fermentations made by the method of the present invention in promoting lipolysis, wherein p is <0.05 compared to a control;
FIG. 8 is a data plot of the utility of plant fermentations made by the present invention in increasing leptin secretion;
FIG. 9 is a data plot showing the efficacy of the method for increasing the growth rate of microorganisms of the present invention in increasing the growth rate of Saccharomyces cerevisiae.
Detailed Description
Definition of
As used herein, the numerical values are approximations and all numerical data are reported to be within the 20 percent range, preferably within the 10 percent range, and most preferably within the 5 percent range.
Statistical analysis was performed using Excel software. Data are presented as mean ± Standard Deviation (SD), and differences between individual data are analyzed by student's t-test (student's t-test).
According to the present invention, rambutan (Nephelus lappacium) is a large tropical fruit tree of the genus Nephelus (Nephelus) of the family Sapindaceae (Sapindaceae), called "rambutan" in Malaysia, which means "hairy antler". The ripe rambutan fruits are not all red, but have yellow fruits. Some rambutan has a nucleus similar in size to sesame. Rambutan has a taste similar to that of litchi, white pulp (aril), transparent and juicy pulp, sweet and sour taste, and contains 1 seed and is flat and oval.
As used herein, the terms "Saccharomyces cerevisiae", "Lactobacillus plantarum" and "Acetobacter aceti" are intended to encompass Saccharomyces cerevisiae, Lactobacillus plantarum and Acetobacter aceti, respectively, which are readily available to those skilled in the art (e.g., from domestic or foreign depositories), or those isolated and purified from natural sources using microbial isolation methods customary in the art.
In accordance with the present invention, the drug may be manufactured using techniques well known to those skilled in the art into a dosage form suitable for parenteral (parenteral), oral (oral) or topical (topically) administration, including, but not limited to: injections (injections) [ for example, sterile aqueous solution (sterile aqueous solution) or dispersion (dispersion) ], sterile powder (sterile powder), troche (tablet), tablet (troche), buccal tablet (dosage), pill (pill), capsule (capsule), dispersible powder (dispersible powder) or granule (granule), solution, suspension (suspension), emulsion (emulsion), syrup (syrup), elixir (elixir), syrup (slurry), external preparation (external preparation), and the like.
According to the present invention, the pharmaceutical may further comprise a pharmaceutically acceptable carrier (pharmaceutically acceptable carrier) which is widely used in pharmaceutical manufacturing technology. For example, the pharmaceutically acceptable carrier may comprise one or more agents selected from the group consisting of: solvents (solvent), buffers (buffer), emulsifiers (emulsifying), suspending agents (suspending agent), disintegrating agents (disintegrant), disintegrating agents (disintegrating agent), dispersing agents (dispersing agent), binding agents (binding agent), excipients (excipient), stabilizers (stabilizing agent), chelating agents (chelating agent), diluents (diluent), gelling agents (gelling agent), preservatives (preserving), wetting agents (wetting agent), lubricants (lubricating), absorption delaying agents (absorption delaying agent), liposomes (liposome) and the like. The selection and amounts of such agents are within the skill and routine skill of those skilled in the art.
According to the present invention, the pharmaceutically acceptable carrier comprises a solvent selected from the group consisting of: water, normal saline (normal saline), Phosphate Buffered Saline (PBS), aqueous alcohol-containing solutions (aqueous solution linking alcohol), and combinations thereof.
According to the invention, the medicament may be administered by a parenteral route (parenteral routes) selected from the group consisting of: intraperitoneal injection (intraperitoneal injection), subcutaneous injection (subcutaneous injection), intraepidermal injection (intraepithelial injection), intradermal injection (intraepithelial injection), intramuscular injection (intramucosal injection), intravenous injection (intravenous injection) and intralesional injection (intrafocal injection).
According to the present invention, pharmaceuticals can be manufactured into an external preparation (external preparation) suitable for topical application to the skin using techniques well known to those skilled in the art, including, but not limited to: creams (lotions), liniments (liniments), powders (powders), aerosols (aerogels), sprays (sprays), emulsions (positions), serums (serums), pastes (pastes), foams (foams), drops (drops), suspensions (suspensions), ointments (salves), and bandages (bandages).
According to the present invention, the external preparation is prepared by mixing the medicine of the present invention with a base (base) as well known to those skilled in the art.
According to the invention, the substrate may comprise one or more additives (additives) selected from the following group: water, alcohols, glycols, hydrocarbons such as petroleum jelly (jelly) and white petrolatum]Wax (wax) [ such as Paraffin and yellow wax (yellow wax)]Preserving agents (preserving agents), antioxidants (antioxidants), surfactants (surfactants), absorption enhancers (absorption enhancers), stabilisers (stabilizing agents), gelling agents (gelling agents) [ such as974P(974P), microcrystalline cellulose (microcrystalline cellulose) and carboxymethyl cellulose (carboxymethyl cellulose)]Active agents (active agents), humectants (humectants), odor absorbers (odor absorbers), fragrances (fragrans), pH adjusting agents (pH adjusting agents), chelating agents (chelating agents), emulsifiers (emulsifiers), occlusive agents (occluvium)e-agents), emollients (emulsifiers), thickeners (thinners), solubilizing agents (solvabilizing agents), penetration enhancers (penetration enhancers), anti-irritants (anti-irritants), colorants (colorants), and propellants (propellants), among others. The selection and amounts of such additives are within the skill and routine skill of those skilled in the art.
According to the present invention, the care product may further comprise an acceptable adjuvant (acceptable adjuvant) which is widely used in the art of care product manufacture. For example, the acceptable adjuvant may comprise one or more agents selected from the group consisting of: solvents, gelling agents, active agents, preservatives, antioxidants, screening agents, chelating agents, surfactants, colouring agents, thickening agents, fillers, fragrances and odour absorbers. The selection and amounts of such agents are within the skill and routine skill of those skilled in the art.
In accordance with the present invention, the cosmetic may be manufactured in a form suitable for skin care (skincare) or makeup (makeup) using techniques well known to those skilled in the art, including, but not limited to: aqueous solutions (aqueous solutions), aqueous-alcoholic solutions (aqueous-alcoholic solutions) or oily solutions (oil solutions), emulsions in the form of oil-in-water type, water-in-oil type or compound type, gels, ointments, creams, masks (masks), patches, wipes, powders, aerosols, sprays, lotions, serums, pastes, foams, dispersions, drops, mousses (mousses), sunblocks, lotions (toiletries), foundations (foundations), make-up removal products (make-up removal products), soaps (soaps) and other body cleansing products (body cleansing products), and the like.
In accordance with the present invention, the cosmetic may also be used in combination with one or more known active topical agents (external use agents) selected from the following: whitening agents (whitening agents) [ such as retinoic acid (tretinoin), catechins (catechin), kojic acid, arbutin and vitamin C ], moisturizers, anti-inflammatory agents (anti-inflammatory agents), bactericides (bacteriodes), ultraviolet absorbers (ultraviolets absorbers), plant extracts [ such as aloe vera extract (aloe vera extract) ], skin nutrients (skin nutrients), anesthetics (anesthesics), anti-acne agents (anti-acne agents), antipruritics (antipruritics), analgesics (analgesics), anti-dermatitis agents (antipermatitis agents), anti-hyperkeratotic agents (anti-hypercholesterolitic agents), anti-dry skin agents (anti-dry skin agents), anti-perspirants (anti-perspirant agents), anti-aging agents (anti-aging agents), anti-wrinkle agents (anti-rinking agents), anti-seborrheic agents (anti-anerrheic agents), wound healing agents (wound-healing agents), corticosteroids (corticosteriods), and hormones (hormones). The selection and amounts of such agents for external use are within the skill and routine skill of those skilled in the art.
According to the present invention, the food product may be used as a food additive (food additive) to be added during the preparation of the raw material or during the preparation of the food by conventional methods, and formulated with any edible material into a food product for ingestion by humans and non-human animals.
According to the present invention, the types of food products include, but are not limited to: beverages (leafages), fermented foods (fermented foods), bakery products (bakery products), health foods (health foods) and dietary supplements (dietary supplements).
Example 1 detection of growth Rate of microorganisms
First, rambutan (Nephelium lappacium) juice from roxburgh city in south thailand was obtained at a ratio of 1: 5-10 wt% of water, and adding glucose with a concentration of 10% (w/w) based on the total weight. Then, extracting for 0.5-1.5 hours at 50-100 ℃ to obtain a plant extract.
Then, after the culture medium of the plant extract is inoculated with Saccharomyces cerevisiae (Saccharomyces cerevisiae) BCRC 20271 to start fermentation, 1mL of bacterial liquid is taken out every 24 hours, and after sequence dilution, the bacterial liquid is coated on a Yeast Peptone Dextrose (YPD) plate, wherein red LED light sources with the wavelength of 620-750 nm (preferably 635nm) are irradiated in the whole fermentation process, and the plant fermentation product irradiating the red LED light sources is obtained. Then, the plant fermentation product irradiated with the red LED light source was used as an experimental group, and the preparation method of the plant fermentation product of the comparative group was substantially the same as that of the experimental group except that: replacing the red LED light source with blue light with the wavelength of 400-450 nm; the preparation method of the plant fermentation product for the control group was substantially the same as that of the experimental group except that: natural light replaces the red LED light source. Subsequently, YPD plates coated with the inoculum solution were placed in an incubator at 30 ℃ for 48 hours, and then colonies were counted to evaluate the growth rate of Saccharomyces cerevisiae. The results of the experiment are shown in FIG. 1.
FIG. 1 is a graph of data for the detection of growth rate of microorganisms. As can be seen from FIG. 1, the growth rate of Saccharomyces cerevisiae was significantly increased in the experimental group compared to the control group and the comparative group. Particularly, in the fermentation process, the red LED light source with the irradiation wavelength of 620-750 nm can increase the growth rate of the saccharomyces cerevisiae by 47% (compared with a control group), and on the contrary, the effect of increasing the growth rate is not achieved when natural light and blue light are irradiated. The results of this example show that illuminating red LED light source in the process of fermenting plants can effectively increase the growth rate of saccharomyces cerevisiae.
Example 2 analysis of content of effective component in plant
First, a standard solution was prepared, 10g of gallic acid (gallic acid) was dissolved in water and a volume of 10mL was added to the measuring flask. Next, 0. mu.L/mL, 20. mu.L/mL, 40. mu.L/mL, 60. mu.L/mL, 80. mu.L/mL, and 100. mu.L/mL of the standard solutions were prepared, and 100. mu.L of each standard solution was taken into a centrifuge tube having a volume of 10 mL. Thereafter, 500. mu.L of Folin-Ciocalteu's phenol reagent was added, mixed and allowed to stand for 3 minutes, and then 400. mu.L of 7.5% sodium carbonate (sodi. mu.M carbonate) was added, mixed and allowed to stand for 30 minutes. Next, 200. mu.L of each reaction solution was transferred to a 96-well plate, and the absorbance was measured at 750 nm.
In addition, the plant fermentation product irradiated with the red LED light source described in example 1 was used as an experimental group, and the preparation method of the plant fermentation product of the control group was substantially the same as the experimental group, except that: natural light replaces the red LED light source. The experimental and control groups were diluted five times with water and 100mL volumes were taken into microcentrifuge tubes. Thereafter, 500. mu.L of the foscarnet reagent was added, mixed and allowed to stand for 3 minutes, and then 400. mu.L of 7.5% sodium carbonate was added, mixed and allowed to stand for 30 minutes. Next, 200. mu.L of each set of the reaction solution was transferred to a 96-well plate, and the absorbance was measured at 750 nm. The results for total polyphenol content are shown in figure 2.
FIG. 2 is a data diagram of the analysis of the content of effective components in plants. As can be seen from fig. 2, the total polyphenol content in the experimental group was significantly increased (increased by 60%) compared to the control group. The results of this example show that irradiation of a red LED light source during plant fermentation can effectively increase the content of active ingredients (i.e., total polyphenols) in the plant (i.e., rambutan).
Example 3 procedure for the method of the invention for fermenting plants
Based on the results of example 1 and example 2, the present inventors decided to prepare a plant fermentation product using a red LED light source. First, rambutan (Nephelium lappacium) juice from roxburgh city in south thailand was obtained at a ratio of 1: 5-10 wt% of water, and adding glucose with a concentration of 10% (w/w) based on the total weight. Then, extracting for 0.5-1.5 hours at 50-100 ℃ to obtain a plant extract. Cooling the plant extract to room temperature for subsequent three-stage fermentation. The three-stage fermentation is to sequentially inoculate 0.01-0.5% (v/v) Saccharomyces cerevisiae BCRC 20271 with the plant extract, and ferment for 1-2.5 days; inoculating 0.01-0.25% (v/v) of Lactobacillus plantarum (TCI 028) (deposited in biological resource preservation and research center of food industry development research institute in 2017, 12 and 13 days, deposited with number BCRC910805) to ferment for 1-3 days; inoculating 3-10% (v/v) acetic acid bacteria (Acetobacter aceti) BCRC 11688 (all the strains are purchased from the Center for biological resource preservation and Research (BCRC) of Food Industry Development Institute (FIRDI) in Taiwan), fermenting for 3-10 days, and irradiating red LED light source with wavelength of 620-750 nm (preferably 635nm) in the whole fermentation process. Then, the mixture is concentrated under reduced pressure at 45 to 70 ℃ and filtered through a 200 to 400 mesh screen. And then, adding 40-70% of isomalto-oligosaccharide, and sterilizing to obtain the plant fermentation product.
Example 4 evaluation of the effectiveness of the fermented product of plants obtained by the method for fermenting plants according to the present invention in enhancing the antioxidant ability of skin
It is reported that after age 35, the antioxidant capacity of human body is greatly reduced, a large amount of free radicals are accumulated, and skin is rapidly aged. Therefore, this example discusses whether the plant fermentation product prepared by the method of example 3 can improve the antioxidant ability of the skin. Using a colorimetric method for reducing iron oxidation capacity (FRAP) to determine the oxidation resistance of the substance to be detected; wherein iron ions (Fe) can be converted by using a specimen having a reducing activity3+) Reduction to ferrous ion (Fe)2+) The color of the solution is changed from reddish brown to green, and the shade of the green compound is in direct proportion to the reduction capability, so that the method can be used for quantifying the reduction activity of the substance to be detected.
First, a calibration curve was prepared using ascorbic acid known to have reducing activity. Precisely weighing 10mL of L-Ascorbic acid (L-Ascorbic acid, Vit C, vitamin C available from Sigma, USA, No. A5960-25g), placing in a 10mL volumetric flask, adding ddH2O was quantified to 10mL, and 1mg/mL of L-ascorbic acid was prepared. Then, 1mL of the prepared L-ascorbic acid was placed in a 10mL volumetric flask, and ddH was added thereto2O was quantified to 10mL to prepare 1. mu.g/mL of L-ascorbic acid, and 100. mu.g/mL of L-ascorbic acid was serially diluted to 0, 10, 20, 40, 60, 80, and 100. mu.L/mL of L-ascorbic acid (as shown in Table 1), 250. mu.L of each concentration of standard solution was added to each test tube, and 250. mu.L of phosphate buffer solution (anhydrous sodium dihydrogen phosphate (NaH) was added thereto2PO4From J.T.Baker, No. 3828-01) and disodium hydrogen phosphate (Na)2HPO4Purchased from Sigma, No. 04270) at a ratio of 1: 1) was mixed well with a shaker (Vortex) and 250 μ L of 1% hematite (Potassium ferricyanide, K) was added3Fe (CN), purchased from Sigma, No. 244023), was mixed well with a shaker and then subjected to a 50 ℃ water bathThe cells were heated for 20 minutes and 250. mu.L of 10% Trichloroacetic acid (TCA, CCl) was added3COOH, from J.T. Baker, No. 0414-01) was mixed well with a shaker, centrifuged at 300g for 10 minutes, and taken out without shaking, then 300. mu.L of the supernatant of each tube of the reaction solution was taken out, and 300. mu.L of ddH was added2O and 120. mu.L of 1% ferric chloride (FeCl)3From Alfa Aesar, No. a16231) was mixed uniformly with a shaker and reacted for 10 minutes, and the absorbance at 700nm was measured to plot the regression curve equation of the standard solution.
TABLE 1 formulation of serially diluted L-ascorbic acid standards
Then, the plant fermentation product obtained in example 3 was used as an experimental group, and the plant fermentation product of the comparative group was prepared in a substantially same manner as that described in example 3 for fermenting plants, except that: natural light replaces the red LED light source. In addition, the plant extract of example 3 was used as a control group. The subsequent experiments were performed after 20-fold dilution of each group of samples. Then, 250. mu.L of each sample was put in 10mL glass test tubes, 250. mu.L of phosphate buffer solution was added and mixed uniformly by a shaker, 250. mu.L of 1% hematite was added and mixed uniformly by a shaker, then the mixture was heated in a 50 ℃ water bath for 20 minutes, 250. mu.L of 10% trichloroacetic acid was added and mixed uniformly by a shaker, and the mixture was centrifuged at 300g for 10 minutes with taking out the supernatant of 300. mu.L of each reaction solution, and 300. mu.L of ddH was added2O and 120 mu L of 1% ferric chloride are uniformly mixed by a shaker, then the mixture reacts for 10 minutes, the light absorption value of the mixture at 700nm is measured, the concentration is calculated by an interior difference method according to the regression curve formula of the standard solution, and then the reduction capacity of each group of samples is obtained by multiplying the dilution times. The results of this example are shown in FIG. 3.
FIG. 3 is a data diagram showing the effect of the plant fermentation product prepared by the method of the present invention on improving the antioxidant ability of skin. As can be seen from fig. 3, the reduction capacity of the experimental group was significantly improved compared to the control group and the comparative group. In particular, the reduction capacity of the experimental group was improved by 57% compared to the control group. The results of this example show that the plant fermentation product prepared by the method for fermenting plants of the present invention can effectively improve the oxidation resistance of skin.
Example 5 evaluation of the Effect of the plant fermentation product obtained by the method for fermenting plants according to the present invention on the enhancement of the anti-glycation Activity of skin
In this example, in order to test the anti-glycation activity of the fermented plant material obtained by the method for fermenting plants according to the present invention, the glycation activity was quantified by the efficiency of inhibiting the glycation of Collagen (Collagen) by D-fructose (D-fructose). Sugar molecules cross-link with proteins to form Advanced glycation end-products (AGEs), which induce intracellular oxidative stress and cause skin aging damage. First, the plant fermentation product prepared in example 3 was used as an experimental group, and the preparation method of the plant fermentation product of comparative group 1 was substantially the same as that for fermenting plants described in example 3, except that: the preparation method of comparative group 2, which replaces the red LED light source with natural light, differs from the method for fermenting plants described in example 3 in that: the plant extract obtained by water extraction was not subjected to three-stage fermentation and red LED light irradiation. The control method was not illuminated and no plant fermentate or extract was added. The subsequent experiments were performed after diluting each group of samples 10-fold. Thereafter, 0.2mL of a solution containing 0.06% NaN was added3And 0.2mL of a 1.5M D-fructose (200 mM sodium phosphate buffer, pH 7.4) solution, taking out 0.1mL of the mixed solution as an origin product, reacting the remaining mixed solution at 50 ℃ for 24 hours, taking out 0.1mL of the mixed solution as an end product, and measuring the fluorescence values of the origin product and the end product at an excitation wavelength of 360nm and an emission wavelength of 460nm, respectively, wherein Aminoguanidine (Aminoguadine, AG) is known to have an effect of inhibiting glycation. Finally, the elimination of high glycation end is calculated by the following formulaEfficiency of product (AGEs) capacity to represent its anti-glycation activity, wherein less production of highly glycated end products indicates higher anti-glycation activity.
The results of this example are shown in FIG. 4. FIG. 4 is a data graph showing the efficacy of the plant fermentation product prepared by the method of the present invention in enhancing the anti-glycation activity of skin. As can be seen from fig. 4, the percentage of glycation ratio in the experimental group was significantly reduced compared to the control group, comparative group 1 and comparative group 2. Wherein the percent glycation ratio of the experimental group is reduced by about 55% compared to the control group. The results of this example show that the plant fermentation product prepared by the method for fermenting plants according to the present invention can effectively improve the ability of removing high-degree glycation end products, and has excellent anti-glycation activity for improving skin.
Example 6 evaluation of the efficacy of the fermented product of plants obtained by the method for fermenting plants according to the present invention in promoting proliferation of elastin (elastin)
In the skin, the elastin is mutually matched with the collagen, which can help support the framework of the skin, improve the elasticity of the skin, strengthen the compactness of the skin and reduce the generation of wrinkles. Therefore, this example discusses whether the plant fermentation product prepared according to the method of example 3 can promote elastin proliferation. First, the plant fermentate prepared in example 3 (0.0625% concentration) was used as an experimental group, and the preparation method of the plant fermentate of the comparative group was substantially the same as the method for fermenting plants described in example 3, except that: natural light replaces the red LED light source. The control method was not illuminated and no plant fermentate or extract was added.
Next, the elastin (elastin) content analysis is performed, the process is as follows: use of FastinTMElastin Assay kit (Elastin Assay kit) inoculates 1X 10 with 2mL of medium in a 6-well plate5The cell line used is human dermal fibroblast CCD-966sk (Number CRL-1881), Minimum Essential Medium (MEM) supplemented with 10% FBS, 1% Penicillin/streptomycin, and 1mM sodium pyruvate (Gibco), and incubated at 37 ℃ for 24 hours. Thereafter, each group of samples was treated with 2mL of the medium and then acted upon for 48 hours. Next, the medium was removed and washed once with 1X PBS, and then the cells were treated with trypsin (trypsin) for 3 minutes. Trypsin activity was stopped with medium and then transferred to a 1.5mL tube. Next, the cells were collected with trypsin and then transferred to a 1.5mL microcentrifuge tube, centrifuged at 300Xg for 5 minutes, and then washed with PBS (Gibco). After this time, the cell pellet was centrifuged at 300Xg for 5 minutes and then retained in about 300. mu.L of PBS. Next, 100. mu.L of 1.0M oxalic acid (oxalic acid) was added to 300. mu.L of the cell suspension and allowed to act in a heating block at 100 ℃ for 1 hour. An equal volume of Elastin precipitation Reagent (Elastin Precipitating Reagent) was added to each tube, the tubes were capped and vortexed briefly and allowed to sit for 15 minutes to complete the precipitation. Thereafter, the liquid contents of the tube were drained by centrifugation at 10,000Xg for 10 minutes, and then the majority of the fluid remaining in the tube was removed by gently tapping the inverted tube onto a paper towel. Next, 1mL of dye reagent was added, the contents were mixed by inverting the tube, and then the tube was placed on a mechanical shaker for 90 minutes. After emptying the unbound dye tube, the elastin-dye complex can be observed as a reddish brown deposit in the bottom of the test tube and in the inner lower wall. To each tube was added 250 μ L of Dye Dissociation Reagent (Dye Dissociation Reagent), the tube was capped and the Dye was released into solution by vortex mixer to ensure that all bound Dye had entered the solution. Thereafter, the contents of each tube were transferred to a 96-well plate, and the plate was placed in an ELISA reader (BioTek) and absorbance was measured at 513 nm.
Next, elastin immunofluorescence staining was performed, the procedure was as follows: inoculation of 5X 10 per well on chamber slides3Human dermal fibroblast CCD-966sk (BCRC code)60153), Minimum Essential Medium (MEM) (Eagle) (Eaglle in Erle's Balanced Salt Solution, Earle's BSS, GIBCO corporation, No. 41500-. Thereafter, cells were fixed with 4% paraformaldehyde (parafumaldehyde) for 10 minutes at room temperature, followed by 3 washes with 1 × PBS, and then 0.2% Triton X-100 (formulated in 1 × PBS (Gibco)) was added to penetrate the cells and allowed to act for 10 minutes at room temperature. Next, 1% BSA (in 1 XPBS) was added, blocked at 37 ℃ for 1 hour, and then washed 3 times with 1 XPBS. Thereafter, a primary antibody (elastin antibody (Merck; MAB2503), diluted with 1% BSA, acted at 37 ℃ for 1 hour) was added and washed 3 times with 1 XPBS. Subsequently, a secondary antibody (anti-mouse-alexa 488 antibody (Thermo), diluted with 1% BSA, acted at 37 ℃ for 1 hour) was added and washed 3 times with 1X PBS. Thereafter, Hoechst 33342(Thermo) was added and allowed to act at room temperature for 3 to 5 minutes, followed by washing 3 times with 1 XPBS. Next, the slide glass was fixed with a fixing gel (mounting gel) and observed under a fluorescent microscope. The results of this example are shown in fig. 5 and fig. 6A and 6B.
FIG. 5 is a data graph showing the efficacy of the plant fermentation product prepared by the method of the present invention in promoting elastin proliferation. FIGS. 6A and 6B are cell staining charts showing the efficacy of the plant fermentation product prepared by the method of the present invention in promoting elastin proliferation. As can be seen from fig. 5, the elastin content in the experimental group is significantly increased compared to the control group and the comparative group. Wherein the elastin content in the experimental group is increased by 13% compared with the control group. As can be seen from FIGS. 6A and 6B, the cell staining pattern of the efficacy of the plant fermentation product obtained by the method of the present invention in promoting elastin proliferation is shown, wherein the dots represent the nucleus and the rest represent elastin. Fig. 6A is the control group of fig. 5, and fig. 6B is the experimental group of fig. 5, and the observation result under the fluorescence microscope shows that the elastin content is more under the action of the plant fermentation product, and the elastin content is improved by 13% as shown in fig. 5 after the data. The results of this example show that the plant fermentation product prepared by the method for fermenting plants of the present invention can effectively promote the proliferation of elastin.
Example 7 evaluation of the effectiveness of the fermented product of plants obtained by the method for fermenting plants according to the present invention in promoting lipolysis
This example was conducted by using mouse bone marrow stromal cells to test the efficacy of the fermented plant material prepared by the method for fermenting plants of the present invention in promoting lipolysis. The mouse bone marrow stromal cells OP9 were purchased from American type culture Collection (American type culture Collection)) Number CRL-2749TM. The cells were cultured in preadipocyte Expansion Medium (Pre-adipocyte Expansion Medium) prior to differentiation, containing 90% minimal essential Medium Alpha Medium (minimum essential Medium Alpha Medium, available from Gibco, usa, 12100-; and mouse bone marrow stromal cells were differentiated using Differentiation Medium comprising 90% minimal essential Medium Alpha Medium, 20% fetal bovine serum, and 1% penicillin/streptomycin.
To confirm that the fermented plant material obtained by the method for fermenting plants according to the present invention has the effect of promoting lipolysis, mouse bone marrow stromal cells were first differentiated into adipocytes (adipocyte) by differentiating 8X 104Mouse bone marrow stromal cells OP9 were seeded in 24-well culture plates with 500. mu.L of preadipocyte Expansion medium and cultured at 37 ℃ for 7 days with replacement of fresh differentiation medium every 3 days. Next, the formation of lipid droplets (lipid droplets) was observed using a microscope (ZEISS) to ensure that the cells had fully differentiated.
OP9 cells were then divided into 3 groups, including 1 control group, 1 comparative group, and 1 experimental group. The plant fermentate obtained according to the method described in example 3 was added to the cells of the experimental group at a concentration of 0.0625%. The preparation of the comparative cell-supplemented material was substantially the same as described in example 3 for the fermentation of plants, except that: natural light replaces the red LED light source. The cells of the control group were not treated. Next, each group of cells was cultured for 7 to 10 days, and the medium was changed every 3 days. Thereafter, Glycerol analysis (Glycerol assay) was performed on each group of cells, with reference to the user's instructions of the Glycerol cell-based assay kit of Cayman.
The decomposition rate of the lipolysis is examined by detecting the amount of glycerol produced. Cell culture supernatants were collected from each well plate, and 25 μ L of cell culture supernatant and standard (standard) were then transferred to a new 96 well plate. Thereafter, 100. mu.L of modified Free Glycerol Assay Reagent (recombinant Free Glycerol Assay Reagent) was added to each well, followed by reaction at room temperature for 15 minutes. Next, the OD of each group was read with ELISA reader (BioTek)540nmAnd (4) light absorption value.
The results of this example are shown in FIG. 7. FIG. 7 is a data graph showing the efficacy of the plant fermentation product prepared by the method of the present invention in promoting lipolysis. As can be seen from fig. 7, the oil droplet content of the experimental group was significantly reduced compared to the control group and the comparative group. The results of this example show that the fermented plant material obtained by the method for fermenting plants according to the present invention has the effect of promoting lipolysis.
Example 8 evaluation of the effectiveness of the fermentation product of plants obtained by the method for fermenting plants according to the invention in increasing leptin secretion
Leptin is an important factor for regulating body weight of human body, can suppress appetite and fat hyperplasia, increase basal metabolic rate and control body fat in a proper range. Many people with long-term obesity have the problem of insufficient secretion of lean voxels, are difficult to lose weight and are easy to regain weight. Thus, this example discusses whether the plant fermentation broth prepared according to the method of example 3 can increase leptin secretion. First, 200. mu.L of preadipocyte Expansion Medium (Pre-adipocyte Expansion Medium) was inoculated into a 96-well plate at 1X 104Mouse adipocytes (Mus musculus, mouse adipo)cyte cell)3T3-L1(Number CL-173TM) Which comprises 90% Dulbecco's Modified Eagle's Medium (available from Gibco), 10% Bovine Serum (obtained from Gibco), and 1% Penicillin/streptomycin (available from Gibco) was added, followed by culturing at 37 ℃ for 48 hours. After 48 hours, the medium was removed and differentiation medium was added for 4 days (fresh differentiation medium was changed every two days) containing 90% Dulbecco's modified Egger's medium, 10% FBS, 1% Penicillin/streptomycin (penicilin-streptomycin), 1.0. mu.M/mL Dexamethasone (DEXA) (Sigma), 0.5mM/mL methyl isobutyl xanthine (Methysobutylxanthine, IBMX) (Sigma), and 1.0. mu.g/mL insulin (insulin) (Sigma). After 4 days, the differentiation Medium was changed to Adipocyte Maintenance Medium (Adipocyte Maintenance Medium) (fresh Maintenance Medium was changed every two days), which contained 90% Dulbecco's modified Egger's Medium, 10% FBS, 1% Penicillin/streptomycin (penicilin-streptomycin), and 1.0. mu.g/mL insulin. After 7 to 10 days after the initiation of the differentiation induction, the cells were completely differentiated, and then the formation of lipid droplets (lipid droplets) was observed with a microscope. After that, each group of samples (concentration 0.0625%) was added and the medium was changed every 48 hours for an additional 12 days. Next, the culture medium was collected and the Leptin content was determined using the Mouse LEP ELISA Kit (Mouse LEP (Leptin) ELISA Kit) (Elabscience). The results of this example are shown in FIG. 8.
FIG. 8 is a data plot of the utility of plant fermentations made by the present invention in increasing leptin secretion. As can be seen from fig. 8, the leptin content in the experimental group was significantly increased compared to the control group and the comparative group. In particular, the lean voxel content of the experimental group was increased by 30% compared to the control group. The results of this example show that the plant fermentation product produced by the method for fermenting plants of the present invention is effective in increasing leptin secretion.
EXAMPLE 9 Process of the method of the present invention for increasing the growth rate of microorganisms
First, rambutan (Nephelium lappacium) juice from roxburgh city in south thailand was obtained at a ratio of 1: 5-10 wt% of water, and adding glucose with a concentration of 10% (w/w) based on the total weight. Then, extracting for 0.5-1.5 hours at 50-100 ℃ to obtain a plant extract.
Then, 0.01-0.5% (v/v) of brewer's Yeast (Saccharomyces cerevisiae) BCRC 20271 is cultured in the culture medium of the plant extract to start fermentation for 1-3 days, 1mL of bacterial liquid is taken out every 24 hours, and after sequence dilution, the bacterial liquid is coated on a Yeast Peptone Dextrose (YPD) plate, wherein the red LED light source with the wavelength of 620-750 nm (preferably 635nm) is irradiated in the whole fermentation process, and the plant fermentation product irradiating the red LED light source is obtained. Then, the plant fermentation product irradiated with the red LED light source was used as an experimental group, and the preparation method of the plant fermentation product of the comparative group was substantially the same as that of the experimental group except that: replacing the red LED light source with blue light with the wavelength of 400-450 nm; the preparation method of the plant fermentation product for the control group is substantially the same as that of the experimental group except that: natural light replaces the red LED light source. Subsequently, YPD plates coated with the inoculum solution were placed in an incubator at 30 ℃ for 48 hours, and then colonies were counted to evaluate the growth rate of Saccharomyces cerevisiae. The results of the experiment are shown in fig. 9.
FIG. 9 is a data plot showing the efficacy of the method for increasing the growth rate of microorganisms of the present invention in increasing the growth rate of Saccharomyces cerevisiae. As can be seen from fig. 9, the growth rate of saccharomyces cerevisiae in the experimental group was significantly increased compared to the control group and the comparative group. Particularly, in the fermentation process, the red LED light source (i.e. experimental group) with the irradiation wavelength of 620-750 nm can increase the growth rate of the saccharomyces cerevisiae by 47% (compared with the control group), otherwise, the effect of increasing the growth rate is not achieved when natural light and blue light are irradiated. The results of this example show that the method for increasing the growth rate of microorganisms of the present invention can effectively increase the growth rate of saccharomyces cerevisiae.
Then, after 5% (v/v) acetic acid bacteria (Acetobacter aceti) BCRC 11688 is inoculated into a culture medium of the plant extract (AAB culture medium, to which 0.5% Yeast extract, 0.3% peptone (peptone) and 2.5% mannitol (mannitol)) and fermentation is started for 1-3 days, 1mL of a bacterial liquid is taken out every 24 hours, and after the bacterial liquid is sequentially diluted, the bacterial liquid is coated on a Yeast peptone dextrose (Yeast dextrose, YPD) plate, wherein a red LED light source with the wavelength of 620-750 nm (preferably 635nm) is irradiated in the whole fermentation process, so as to obtain the plant fermentation product irradiated by the red LED light source. Then, the plant fermentation product irradiated with the red LED light source was used as an experimental group, and the preparation method of the plant fermentation product of the comparative group was substantially the same as that of the experimental group except that: replacing the red LED light source with blue light with the wavelength of 400-450 nm; the preparation method of the plant fermentation product for the control group was substantially the same as that of the experimental group except that: natural light replaces the red LED light source. Subsequently, YPD plates coated with the inoculum solution were placed in an incubator at 30 ℃ for 48 hours, and then colonies were counted to evaluate the growth rate of acetic acid bacteria. The results of the experiment are shown in table 2.
TABLE 2
Group of | Growth rate of acetic acid |
Control group | |
100% | |
Comparison group | 89% |
Experimental group | 122% |
As can be seen from Table 2, the growth rate of acetic acid bacteria in the experimental group was significantly increased compared to the control group and the comparative group. Particularly, in the fermentation process, the red LED light source (i.e. experimental group) with the irradiation wavelength of 620-750 nm can increase the growth rate of acetic acid bacteria by 22% (compared with the control group), otherwise, the effect of increasing the growth rate is not achieved when natural light and blue light are irradiated. The results of this example show that the method for increasing the growth rate of microorganisms of the present invention can effectively increase the growth rate of acetic acid bacteria.
In summary, the method for fermenting plants and the plant fermentation product prepared by the method of the invention can increase the growth rate of microorganisms (such as saccharomyces cerevisiae and acetic acid bacteria) and the content of effective components in plants, and achieve the effects of skin care and skin beautification by increasing the oxidation resistance of skin, improving the anti-saccharification activity of skin and promoting the proliferation of elastin. On the other hand, the plant fermentation product can achieve the effect of reducing fat by promoting lipolysis and increasing leptin secretion.
The foregoing is by way of example only, and not limiting. It is intended that all equivalent modifications or variations without departing from the spirit and scope of the present invention shall be included in the claims.
Claims (20)
1. A method for fermenting a plant comprising the steps of:
extracting a plant with water to obtain a plant extract; and
sequentially fermenting the plant extract with Saccharomyces cerevisiae, Lactobacillus plantarum and Acetobacter xylinum to obtain a plant fermented product,
wherein the fermentation process comprises irradiating the plant extract, the brewer's yeast, the germ lactic acid bacteria, and the acetic acid bacteria with a red light source having a wavelength of 620-750 nm.
2. The method of claim 1, wherein the plant is rambutan.
3. The method of claim 1, wherein prior to said extracting, a concentration of 10% (w/w) glucose based on total weight is added.
4. The method of claim 1, wherein the fermentation time of the saccharomyces cerevisiae is 1 to 2.5 days, the fermentation time of the germ lactic acid bacteria is 1 to 3 days, and the fermentation time of the acetic acid bacteria is 3 to 10 days.
5. The method of claim 1, wherein the concentration of Saccharomyces cerevisiae is 0.01-0.5% (v/v), the concentration of Lactobacillus plantarum is 0.01-0.25% (v/v), and the concentration of Acetobacter xylinum is 3-10% (v/v).
6. The method according to claim 1, wherein the weight ratio of the plant to the water is 1: 5-10.
7. The method of claim 1, wherein the temperature of the extraction is between 50 and 100 ℃ and the time of the extraction is between 0.5 and 1.5 hours.
8. Use of the method of any one of claims 1 to 7 for increasing the growth rate of saccharomyces cerevisiae and the content of active ingredients in plants.
9. Use according to claim 8, characterized in that the plant is rambutan and the active ingredient is a polyphenol.
10. A plant fermentation obtained by the method according to any one of claims 1 to 7.
11. Use of the plant ferment of claim 10 for the preparation of a skin-care and fat-reducing composition.
12. The use of claim 11, wherein the skin care comprises enhancing the antioxidant capacity of the skin, enhancing the anti-glycation activity of the skin, and promoting elastin proliferation.
13. The use of claim 11, wherein the fat reduction comprises promoting lipolysis and increasing lean voxel secretion.
14. The use according to claim 11, wherein the composition is in the form of a medicament, a nutraceutical or a food product.
15. A method for increasing the growth rate of a microorganism, comprising the steps of:
extracting a plant with water to obtain a plant extract; and
subjecting the plant extract to a fermentation process with a microorganism to obtain a plant fermentation product,
wherein the microorganism is Saccharomyces cerevisiae or Acetobacter xylinum, and the fermentation process comprises irradiating the plant extract and the microorganism with a red light source with a wavelength of 620-750 nm.
16. The method of claim 15, wherein the plant is rambutan.
17. The method of claim 15, wherein prior to said extracting, a concentration of 10% (w/w) glucose is added based on total weight.
18. The method of claim 15, wherein the fermentation time of the microorganism is 1 to 3 days.
19. The method of claim 15, wherein the concentration of Saccharomyces cerevisiae is 0.01-0.5% (v/v), and the concentration of Acetobacter is 5% (v/v).
20. The method of claim 15, wherein the growth rate of the brewer's yeast is increased by at least 47% and the growth rate of the acetic acid bacteria is increased by at least 22%.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201962850043P | 2019-05-20 | 2019-05-20 | |
US62/850,043 | 2019-05-20 |
Publications (1)
Publication Number | Publication Date |
---|---|
CN111956707A true CN111956707A (en) | 2020-11-20 |
Family
ID=73357911
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN202010021634.0A Pending CN111956707A (en) | 2019-05-20 | 2020-01-09 | Method for improving growth speed of saccharomyces cerevisiae and content of effective components in plants by using red light |
Country Status (2)
Country | Link |
---|---|
CN (1) | CN111956707A (en) |
TW (1) | TWI737086B (en) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN115192620A (en) * | 2021-04-14 | 2022-10-18 | 大江生医股份有限公司 | Use of eucheuma fermentation product for preparing composition for improving metabolic state |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104099231A (en) * | 2014-07-05 | 2014-10-15 | 彭常安 | Rambutan fruit vinegar preparation method |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2325295A3 (en) * | 2005-09-12 | 2013-05-29 | Vrije Universiteit Brussel | Cacao starter cultures and fermentation method |
CN105943577B (en) * | 2016-04-29 | 2018-02-13 | 刘东波 | The microbial fermentation of autonomic drug |
US10426811B2 (en) * | 2016-08-25 | 2019-10-01 | Tci Co., Ltd. | Banana fermentation product and manufacturing method and use of the same |
-
2019
- 2019-12-18 TW TW108146489A patent/TWI737086B/en active
-
2020
- 2020-01-09 CN CN202010021634.0A patent/CN111956707A/en active Pending
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN104099231A (en) * | 2014-07-05 | 2014-10-15 | 彭常安 | Rambutan fruit vinegar preparation method |
Non-Patent Citations (4)
Title |
---|
无: "女性常皮肤不好?多食用此菜,美容养颜,延缓衰老,还能减肥", 《HTTP://WWW.VI321.NET/MEIRO/20174.HTML》 * |
李建强等: "酵素三级发酵与自然发酵过程中SOD活性变化的研究", 《轻工科技》 * |
马丹丹: "红,蓝光对细菌生长及产物性能的影响", 《工程与材料科学》 * |
马丹丹等: "红/蓝光对粘红酵母生长及产物产量的影响", 《食品与机械》 * |
Also Published As
Publication number | Publication date |
---|---|
TWI737086B (en) | 2021-08-21 |
TW202108164A (en) | 2021-03-01 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
TWI693899B (en) | Fermentation product of punica granatum and uses thereof | |
JP6322580B2 (en) | Soymilk fermented extract and hypocotyl fermented extract | |
WO2009145419A2 (en) | Composition comprising vegetable peptone for promoting stem cell proliferation | |
CN111534455B (en) | Preparation of lactobacillus sporolysis product and application of lactobacillus sporolysis product in cosmetics | |
KR20210037153A (en) | Cosmetic composition comprising the sprout fermentation and preparation method thereof | |
KR20160065245A (en) | Composition of culture medium for cultivation of Lactobacillus, ginseng berry-fermented extracts comprising thereof and cosmetic composition for improving skin conditions | |
TWI774046B (en) | Use of solanum muricatum fermented liquid for preparing a composition for promoting skin anti-aging ability, promoting anti-glycation ability, reducing melanin content, increasing skin moisturization, reducing skin texture, reducing skin wrinkles, reducing skin redness and/or reducing fat | |
CN111956707A (en) | Method for improving growth speed of saccharomyces cerevisiae and content of effective components in plants by using red light | |
JP2023171950A (en) | Anti-aging agent, antioxidant, anti-inflammatory agent, and whitening agent, as well as cosmetic | |
KR20190063549A (en) | Cosmetic Composition Comprising Bamboo Fermented Extract | |
JP7002915B2 (en) | External skin preparation containing Saccharomyces yeast fermented liquid of collagen | |
CN116211764A (en) | Composition, fermentation product thereof and application of fermentation product in preparation of cosmetics | |
US20220062160A1 (en) | Method for inhibiting skin acne formation, reducing cutibacterium acnes secretions, and/or reducing advanced glycation end-products using wasabia japonica leaf extract | |
CN106176564B (en) | The method for preparing ginseng PORIA ALBA fermentation liquid using ginseng endogenetic fungus | |
CN111617025B (en) | Fermentation product cosmetic for whitening, removing freckles and resisting saccharification | |
WO2021217693A1 (en) | Use of symbiotic fermentation product of hydrolyzed candida and japanese sake yeast | |
CN113855765A (en) | Glutinous rice fermented extract and anti-aging application thereof | |
TWI674107B (en) | Use of imperata cylindrica fermented extract for enhancing the gene expression of keratin, filaggrin and hyaluronan synthase, promoting the proliferation of collagen and elastin, and enhancing antioxidant capacity of skin cells | |
CN110151672B (en) | Application of lactobacillus plantarum GMNL-6 composition in skin care | |
CN111939182A (en) | Application of ginkgo callus extract and method for culturing ginkgo callus | |
CN112438922B (en) | Application of mangosteen fermentation liquor in preparation of composition for beautifying skin and/or reducing fat | |
TWI680772B (en) | A use of lactobacillus plantarum gmnl-6 composition for caring skin | |
CN113876833B (en) | White mulberry fermented product and preparation method and application thereof | |
CN115948480B (en) | Flos mori fermentation liquor with antioxidant, anti-inflammatory and brightening effects and preparation method and application thereof | |
JP6969760B2 (en) | Composition that promotes hair growth |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination |